This study compound was 1st reported by Hoffman-La Roche in 2009. It’s one among various benzodiazepines while in the imidazobenzodiazepine subgroup considered to offer nootropic Gains.More investigate is needed to be familiar with if and why GL-II-seventy three has nootropic Rewards and whether it’s safe to work with therefore. Tingjunhong Ni